The impact of using an intraoperative goal directed fluid therapy protocol on clinical outcomes in patients undergoing total pancreatectomy and islet cell autotransplantation

Matthew K. Wagar, Josh Magnuson, Patty T. Liu, Varvara Kirchner, Joshua J. Wilhelm, Martin L. Freeman, Melena D. Bellin, Timothy L. Pruett, Gregory J. Beilman, Ty B. Dunn

Research output: Contribution to journalArticle

3 Scopus citations


Background Patients undergoing total pancreatectomy and islet cell autotransplant (TPIAT) for treatment of pancreatitis are at risk for complications of over and under resuscitation. We hypothesized that using a goal directed fluid therapy (GDFT) protocol might impact clinical outcomes. Materials and methods A consecutive series of adult patients undergoing TPIAT were managed intraoperatively using either standard fluid therapy (SFT, n = 44) or GDFT (n = 23) as part of a pilot study between January 2013 and May 2015. Patient characteristics, intraoperative, and postoperative data were recorded prospectively, then retrospectively analyzed for differences between the groups. Results The GDFT group had lower total fluid resuscitation (3,240 cc vs 5,173 cc, p < 0.0001) and transfusion requirements (1.0 cc/kg vs 3.3 cc/kg, p = 0.050) compared to the SFT group. The pre to postop nadir hemoglobin change was significantly less for GDFT (4.2 vs 5.1 gm/dl, p = 0.021) despite less transfusion. Conclusions Compared to SFT, using an intraoperative GDFT protocol in TPIAT patients was associated with significantly decreased intraoperative fluid resuscitation, blood transfusion and less postoperative dilutional anemia, without any difference in complications of underresuscitation. This pilot study suggests that GDFT is likely safe and further investigation is warranted.

Original languageEnglish (US)
Pages (from-to)586-591
Number of pages6
Issue number4
StatePublished - Jul 2017



  • Goal directed therapy
  • Islet cell
  • Pancreatic surgery
  • Pancreatitis

Cite this